Officer received an award of 40K HALO derivative securities | OQRO Insider tradesWhy it stands out
Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Jul 1, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- Jul 2, 2026
OfficerGrant / award
Context
- Classification
grant award
Code A — grant or award
- Planned / mechanical clue
None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0001159036-26-000096
- Filed / recorded
Jul 2, 2026, 8:45 PM UTCAdded to OQROOct 6, 2026, 7:59 PM UTC Data qualityVerified: identifiers matched exactly IssuerHALOZYME THERAPEUTICS, INC. Reporting personDavid A Ramsay Officer titleEVP, PRESIDENT, DRUG DELIVERY SecurityOption to Purchase Common Stock TableDerivative (Table II) Transaction dateJul 1, 2026 Acquired / disposedAcquired (A) Footnotes from the filing
- This option vests one-fourth on such date and then 1/48th monthly thereafter.